Legal Opinion
Liquidia Technologies, Inc. v. United States Food and Drug Administration
District Court, District of Columbia
Decided February 27, 2025No. Civil Action No. 2024-2428Published
1Opinion of the Court
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA LIQUIDIA TECHNOLOGIES, INC., Plaintiff, v. FOOD AND DRUG ADMINISTRATION et al., Civil Action No. 24-2428 (TJK) Defendants, v. UNITED THERAPEUTICS CORPORATION, Intervenor-Defendant. MEMORANDUM OPINION On August 16, 2024, the U.S. Food and Drug Administration tentatively approved Plaintiff Liquidia Technologies, Inc.’s, New Drug Application for its proposed drug Yutrepia, a treprostinil inhalation powder designed to treat two types of pulmonary arterial hypertension. But that ap- proval was only tentative because FDA determined that…
2Cases cited19 opinions
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Securities & Exchange Commission v. Chenery Corp.Supreme Court of the United States · 1947
- United Sav. Assn. of Tex. v. Timbers of Inwood Forest Associates, Ltd.Supreme Court of the United States · 1988
- National Cable & Telecommunications Assn. v. Brand X Internet ServicesSupreme Court of the United States · 2005
- Federal Communications Commission v. Fox Television Stations, Inc.Supreme Court of the United States · 2009
14 more not listed; retrieve them via the Exa API.